“dan-bradbury” Archives

in
Entry Author Date Location
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease 02/28/19 San Diego
Building Biotechs to Last: A Sneak Peek at the Agenda for Dec. 9 11/19/13 San Francisco
How Did Your Biotech Company Get Out of a Jam? Join Us Dec. 9 in SF 11/13/13 San Francisco
Building Biotechs to Last: See Bonnie Anderson, Dan Bradbury & More 11/07/13 Boston
Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact 11/08/11 San Diego
Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News 07/28/11 San Diego
San Diego’s Fight Against Diabesity: The Photo Gallery 01/28/11 San Diego
Novartis Acquires Genoptix, Elcelyx Raises $6M, Pfenex Gets Subcontract to Work on Malaria Treatment, & More San Diego Life Sciences News 01/27/11 San Diego
Amylin Keeps Its Chin Up After A Rough 2010 With New Diabetes Drug 01/21/11 San Diego
J&J Subsidiary Backs Alzheimer Drug Discovery at Sanford-Burnham, Portable Genomics to Move to San Diego, Ardea Plans Secondary Stock Offering, & More San Diego Life Sciences News 01/20/11 San Diego
San Diego’s Quest to Fight the “Diabesity” Epidemic, Coming Jan. 27 01/13/11 San Diego
How Can San Diego Win the Fight Against Diabesity? Xconomy to Dig Deep on Jan. 27 12/27/10 San Diego
San Diego’s Fight Against Diabesity: Can Investors Make Money, and Can Startups Still Thrive? 12/03/10 San Diego
The Fight Against Diabesity: How Will San Diego Adapt in the Era of Tough FDA Scrutiny? 11/22/10 San Diego
CareFusion Hits Acquisition Trail, Cadence Pharmaceuticals Enlists Manufacturing Expertise, Medsphere Systems Sees Explosion in Bookings, & More San Diego Life Sciences News 04/08/10 San Diego
San Diego Biotech in 2030: A Center for Stem Cells, Genomics, Software, Neuroscience 04/02/10 San Diego
See You Tonight at San Diego Life Sciences 2030 03/31/10 San Diego
The 20-Year Outlook for San Diego Life Sciences: Sold Out? Not Anymore 03/15/10 San Diego
Amylin, Alkermes Sit in Suspense For FDA Verdict on Once-Weekly Diabetes Drug 03/10/10 National
The 20-Year Future of San Diego Biotech, Coming March 31 03/09/10 San Diego
What Will San Diego’s Biotech Hub Look Like in 20 Years? Xconomy Event Takes Long View 02/16/10 San Diego
Amylin Braces for Big Event of 2010, the (Hoped-For) Approval of Once-Weekly Diabetes Drug 01/22/10 San Diego
Amylin Strikes $1 Billion Deal with Takeda to Co-Develop Weight Loss Drugs 11/02/09 San Diego
Amylin CEO, Putting Boardroom Coup Behind Him, Turns Up Heat on New Diabetes Drug 09/29/09 San Diego
Amylin Cuts 200 Sales Reps, Looks for $45M in Savings Next Year 05/04/09 San Diego
Departed Amylin Co-Founder Greene Says Company in ‘Perfect Storm,’ But Confident in Management 04/13/09 San Diego
Page 1 of 1